Fuller & Thaler Asset Management Inc. Sells 43,926 Shares of Bruker Co. (NASDAQ:BRKR)

Fuller & Thaler Asset Management Inc. decreased its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 11.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 334,534 shares of the medical research company's stock after selling 43,926 shares during the quarter. Fuller & Thaler Asset Management Inc. owned about 0.22% of Bruker worth $19,610,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Eagle Bay Advisors LLC raised its position in shares of Bruker by 2,324.1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock valued at $41,000 after acquiring an additional 674 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Bruker by 37.5% during the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock worth $53,000 after purchasing an additional 248 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Bruker by 18.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company's stock worth $75,000 after buying an additional 196 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Bruker by 47.5% in the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock valued at $75,000 after buying an additional 412 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Bruker by 41.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company's stock valued at $78,000 after buying an additional 390 shares during the last quarter. 79.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on BRKR shares. Citigroup dropped their price target on Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday, April 7th. Barclays cut their price objective on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Wells Fargo & Company cut their price target on Bruker from $75.00 to $60.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Stifel Nicolaus lowered their target price on Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a research report on Friday, February 14th. Finally, Guggenheim reissued a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $65.00.

Bruker Stock Performance

NASDAQ BRKR traded up $0.59 during trading on Monday, hitting $39.66. The company's stock had a trading volume of 1,848,009 shares, compared to its average volume of 1,521,847. Bruker Co. has a 52 week low of $34.10 and a 52 week high of $82.04. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The firm has a market cap of $6.01 billion, a P/E ratio of 52.18, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. The firm has a 50 day moving average price of $43.22 and a 200 day moving average price of $52.62.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Equities research analysts forecast that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend was Monday, March 17th. Bruker's payout ratio is presently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.